AtriCure, Inc. (ATRC) Posts Q3 EPS Loss of $0.07
Tweet
Share
E-mailGet Alerts ATRC Hot Sheet
Price: $28.79 +1.34%
EPS Growth %: +92.3%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
PLCE, COE, JVA, More
EPS Growth %: +92.3%
Financial Fact:
Research and development expenses: 8.27M
Today's EPS Names:
PLCE, COE, JVA, More
Join SI Premium – FREE
AtriCure, Inc. (NASDAQ: ATRC) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $15.2 million versus the consensus estimate of $15.88 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Lennar Corp. (LEN) Misses Q2 EPS by 1c
- Anterix Inc. (ATEX) Tops Q4 EPS by 152c
- Adobe Systems (ADBE) Tops Q2 EPS by 14c, Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
